XML 89 R75.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Compensation Plans (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Restricted Stock [Member]      
Share-based Compensation Arrangements by Share-based Payment Award, Restricted Stock, Nonvested, Number of Shares [Roll Forward]      
Non-vested shares awarded, beginning of period (in shares) 489,554 420,234 427,178
Non-vested shares that were granted during the period (in shares) 183,809 247,917 236,750
Non-vested shares that vested during period (in shares) (139,859) (166,965) (225,527)
Non-vested shares that forfeited during period (in shares) (40,620) (11,632) (18,167)
Non-vested shares awarded, end of period (in shares) 492,884 489,554 420,234
Share-based Compensation Arrangements by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Weighted Average Grant Date Fair Value, Granted $ 108.23 $ 73.01 $ 83.49
Weighted Average Grant Date Fair Value, Vested 76.80 94.96 83.50
Weighted average grant date fair value non-vested share awards forfeited (in dollars per share) $ 79.60 $ 75.83 $ 83.10
Share-based Compensation Costs, Including Costs That May Be Recognized As Future Expense [Abstract]      
Share-based Compensation Expense Recognized $ 9,000 $ 9,300 $ 16,000
Unrecognized compensation cost of unvested awards, for future periods 15,500    
Unrecognized compensation cost of unvested awards, Amount to be expensed in 2023 8,800    
Unrecognized compensation cost of unvested awards, Amount to be expensed in 2024 6,300    
Unrecognized compensation cost of unvested awards, Amount to be expensed in 2025 $ 386    
Number of shares with required performance obligations 58,098    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 15,000 $ 13,000 $ 19,500
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangements by Share-based Payment Award, Restricted Stock, Nonvested, Number of Shares [Roll Forward]      
Non-vested shares awarded, beginning of period (in shares) 87,239 69,669 46,689
Non-vested shares that were granted during the period (in shares) 25,416 17,570 22,980
Non-vested shares that vested during period (in shares) (61,645) 0 0
Non-vested shares that forfeited during period (in shares) 0 0 0
Non-vested shares awarded, end of period (in shares) 51,010 87,239 69,669
Share-based Compensation Arrangements by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Weighted Average Grant Date Fair Value, Granted $ 103.79 $ 88.25 $ 77.36
Weighted Average Grant Date Fair Value, Vested 91.38 0 0
Weighted average grant date fair value non-vested share awards forfeited (in dollars per share) $ 0 $ 0
Share-based Compensation Costs, Including Costs That May Be Recognized As Future Expense [Abstract]      
Share-based Compensation Expense Recognized $ 597 $ 4,000 $ 2,200
Unrecognized compensation cost of unvested awards, for future periods 932    
Unrecognized compensation cost of unvested awards, Amount to be expensed in 2023 578    
Unrecognized compensation cost of unvested awards, Amount to be expensed in 2024 342    
Unrecognized compensation cost of unvested awards, Amount to be expensed in 2025 $ 13    
Number of shares with required performance obligations 8,258    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested $ 6,300 $ 0 $ 0